Reconstruction of Protein Networks Using Reverse-Phase Protein Array Data

  • Silvia von der Heyde
  • Johanna Sonntag
  • Frank Kramer
  • Christian Bender
  • Ulrike Korf
  • Tim Beißbarth
Part of the Methods in Molecular Biology book series (MIMB, volume 1362)

Abstract

In this chapter, we describe an approach to reconstruct cellular signaling networks based on measurements of protein activation after different stimulation experiments. As experimental platform reverse-phase protein arrays (RPPA) are used. RPPA allow the measurement of proteins and phosphoproteins across many samples in parallel with minimal sample consumption using a panel of highly target protein-specific antibodies. Functional interactions of proteins are modeled using a Boolean network. We describe the Boolean network reconstruction approach ddepn (dynamic deterministic effects propagation networks), which uses time course data to derive protein interactions based on perturbation experiments. We explain how the method works, give a practical application example, and describe how the results can be interpreted. Furthermore prior knowledge on signaling pathways is essential for network reconstruction. Here we describe the use of our software rBiopaxParser to integrate prior knowledge on protein signaling available in public databases. All applied methods are freely available as open-source R software packages. We describe the preparation of RPPA data as well as all relevant programming steps to format the RPPA data, to infer the prior knowledge, and to reconstruct and analyze the protein signaling networks.

Key words

Reverse-phase protein arrays Proteomics Protein signaling DDEPN Network reconstruction Boolean modeling 

References

  1. 1.
    Wang R-S, Saadatpour A, Albert R (2012) Boolean modeling in systems biology: an overview of methodology and applications. Phys Biol 9:055001CrossRefPubMedGoogle Scholar
  2. 2.
    von der Heyde S, Bender C, Henjes F et al (2014) Boolean ErbB network reconstructions and perturbation simulations reveal individual drug response in different breast cancer cell lines. BMC Syst Biol 8:75CrossRefPubMedGoogle Scholar
  3. 3.
    Bender C, vd Heyde S, Henjes F et al (2011) Inferring signalling networks from longitudinal data using sampling based approaches in the R-package “ddepn”. BMC Bioinformatics 12:291PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Eduati F, De Las Rivas J, Di Camillo B et al (2012) Integrating literature-constrained and data-driven inference of signalling networks. Bioinformatics 28:2311–2317PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Schaefer CF, Anthony K, Krupa S et al (2009) PID: the Pathway Interaction Database. Nucleic Acids Res 37:D674–D679PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Nishimura D (2001) BioCarta. Biotech Softw Internet Rep 2:117–120CrossRefGoogle Scholar
  7. 7.
    Croft D, O’Kelly G, Wu G et al (2011) Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res 39:D691–D697PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Demir E, Cary MP, Paley S et al (2010) The BioPAX community standard for pathway data sharing. Nat Biotechnol 28:935–942PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    R Development Core Team (2013) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org. Accessed 1 Feb 2015
  10. 10.
    Kramer F, Bayerlová M, Klemm F et al (2013) rBiopaxParser—an R package to parse, modify and visualize BioPAX data. Bioinformatics 29:520–522CrossRefPubMedGoogle Scholar
  11. 11.
    Henjes F, Bender C, von der Heyde S et al (2012) Strong EGFR signaling in cell line models of ERBB2-amplified breast cancer attenuates response towards ERBB2-targeting drugs. Oncogenesis 1, e16PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Korf U (ed) (2011) Protein microarrays—methods and protocols. Springer Science+Business Media, LLC, New YorkGoogle Scholar
  13. 13.
    Akbani R, Becker K-F, Carragher N et al (2014) Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society. Mol Cell Proteomics 13:1625–1643PubMedCentralCrossRefPubMedGoogle Scholar
  14. 14.
    Loebke C, Sueltmann H, Schmidt C et al (2007) Infrared-based protein detection arrays for quantitative proteomics. Proteomics 7:558–564CrossRefPubMedGoogle Scholar
  15. 15.
    Sonntag J, Bender C, Soons Z et al (2014) Reverse phase protein array based tumor profiling identifies a biomarker signature for risk classification of hormone receptor-positive breast cancer. Transl Proteomics 2:52–59CrossRefGoogle Scholar
  16. 16.
    von der Heyde S, Sonntag J, Kaschek D et al (2014) RPPanalyzer toolbox: an improved R package for analysis of reverse phase protein array data. Biotechniques 57:125–135PubMedGoogle Scholar
  17. 17.
    Bader GD, Cary MP, Sander C (2006) Pathguide: a pathway resource list. Nucleic Acids Res 34:D504–D506PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Ogata H, Goto S, Sato K et al (1999) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 27:29–34PubMedCentralCrossRefPubMedGoogle Scholar
  19. 19.
    Joshi-Tope G, Gillespie M, Vastrik I et al (2005) Reactome: a knowledgebase of biological pathways. Nucleic Acids Res 33:D428–D432PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    Kelder T, van Iersel MP, Hanspers K et al (2012) WikiPathways: building research communities on biological pathways. Nucleic Acids Res 40:D1301–D1307PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Werhli AV, Husmeier D (2007) Reconstructing gene regulatory networks with bayesian networks by combining expression data with multiple sources of prior knowledge. Stat Appl Genet Mol Biol 6, Article15Google Scholar
  22. 22.
    Fröhlich H, Tresch A, Beissbarth T (2009) Nested effects models for learning signaling networks from perturbation data. Biom J 51:304–323CrossRefPubMedGoogle Scholar
  23. 23.
    Mukherjee S, Speed TP (2008) Network inference using informative priors. Proc Natl Acad Sci U S A 105:14313–14318PubMedCentralCrossRefPubMedGoogle Scholar
  24. 24.
    Kramer F, Bayerlová M, Beißbarth T (2014) R-based software for the integration of pathway data into bioinformatic algorithms. Biology (Basel) 3:85–100Google Scholar
  25. 25.
    Gray KA, Yates B, Seal RL et al (2014) Genenames.org: the HGNC resources in 2015. Nucleic Acids Res 43:D1079–D1085PubMedCentralCrossRefPubMedGoogle Scholar
  26. 26.
    Durinck S, Moreau Y, Kasprzyk A et al (2005) BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics 21:3439–3440CrossRefPubMedGoogle Scholar
  27. 27.
    Pruitt K, Brown G, Tatusova T et al (2002) The Reference sequence (RefSeq) database. In: McEntyre J, Ostell J (eds) The NCBI handbook [Internet], Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information, Chapter 18. http://www.ncbi.nlm.nih.gov/books/NBK21091. Accessed 1 Feb 2015
  28. 28.
    Mannsperger HA, Gade S, Henjes F et al (2010) RPPanalyzer: analysis of reverse-phase protein array data. Bioinformatics 26:2202–2203CrossRefPubMedGoogle Scholar
  29. 29.
    Brooks SP, Gelman A (1998) General methods for monitoring convergence of iterative simulations. J Comput Graph Stat 7:434–455Google Scholar
  30. 30.
    Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 57:289–300Google Scholar
  31. 31.
    Junttila TT, Akita RW, Parsons K et al (2009) Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941. Cancer Cell 15:429–440CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Silvia von der Heyde
    • 1
    • 2
  • Johanna Sonntag
    • 3
  • Frank Kramer
    • 1
  • Christian Bender
    • 4
  • Ulrike Korf
    • 3
  • Tim Beißbarth
    • 1
  1. 1.Department of Medical StatisticsUniversity Medical Center GöttingenGöttingenGermany
  2. 2.IndivuTest GmbHHamburgGermany
  3. 3.Division of Molecular Genome AnalysisGerman Cancer Research Center (DKFZ)HeidelbergGermany
  4. 4.TRON-Translational Oncology at the University Medical Center MainzMainzGermany

Personalised recommendations